ORPEA Announces the Sale of 22 Residential Care Facilities in the Netherlands to Amvest Living & Care for a Total Amount of 85 Million Euros
30 Agosto 2023 - 11:00AM
Business Wire
Regulatory News:
This summer, ORPEA (Paris:ORP) signed an agreement with Amvest
Living & Care Fund for the sale of a portfolio of 22 facilities
under development, located in the Netherlands, which will
eventually provide care to 480 residents. This new sale and
leaseback agreement, worth €85 million, will bring to 75 the number
of homes owned by Amvest and operated by its subsidiary Dagelijks
Leven.
For several years now, Dagelijks Leven has been developing an
innovative concept in the Netherlands for specialised care and
accommodation for elderly people with cognitive disorders,
characterized by an affordable price positioning within a low-scale
setting (accommodating a maximum of 22 residents).
These homes, which construction will be achieved over 2023, 2024
and the first half of 2025, will be spread throughout the
Netherlands. The first two facilities in this portfolio, located in
the towns of Culemborg and Hardenberg, were handed over on the 10th
of August 2023.
Following on from the disposals completed in July 2023, these
transactions are fully in line with the targeted property asset
ownership strategy set out in the ORPEA Group's Refoundation Plan,
which aims at achieving a 20% to 25% ownership rate of operated
assets in the medium term. They also illustrate the Group’s
ability, via its subsidiary Dagelijks Leven, to meet the
expectations of a long-term investor committed to developing an
innovative range of care and hospitality services in local
areas.
About ORPEA
ORPEA is a leading global player, expert in providing care for
all types of frailty. The Group operates in 21 countries and covers
three core businesses: care for the elderly (nursing homes,
assisted living facilities, homecare and services), post-acute and
rehabilitation care and mental health care (specialized clinics).
It has more than 76,000 employees and welcomes more than 267,000
patients and residents each year.
https://www.orpea-group.com/en
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a
member of the SBF 120, MSCI Small Cap Europe and CAC Mid 60
indices.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230830048681/en/
Investor Relations ORPEA Benoit Lesieur Investor
Relations Director b.lesieur@orpea.net
Toll-free number for shareholders : 0 805 480 480
Investor Relations NewCap Dusan Oresansky Tel: 01
44 71 94 94 ORPEA@newcap.eu
Press Relations ORPEA Isabelle Herrier-Naufle
Press Relations Director Tel: 07 70 29 53 74
i.herrier-naufle@orpea.net
Image7 Charlotte Le Barbier // Laurence Heilbronn 06 78
37 27 60 - 06 89 87 61 37 clebarbier@image7.fr
lheilbronn@image7.fr
Orpea (EU:ORP)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Orpea (EU:ORP)
Gráfica de Acción Histórica
De May 2023 a May 2024